Mark For: NITYR® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 87604011 |
Registration Number | 5716643 |
Mark Literal Elements | NITYR |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Trademark, Service Mark |
Current Location | PUBLICATION AND ISSUE SECTION 2019-02-26 |
Basis | 1(a) 44(e) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | Yes |
Intent To Use | No |
Filed ITU | Yes |
44D Filed | Yes |
44E Current | Yes |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Kristin Grant |
Law Office Assigned | M20 |
Employee Name | BELENKER, ESTHER ANN |
2017-08-01 | Date of First Use |
2017-08-01 | Date of Use In Commerce |
2017-09-11 | Application Filed |
2018-09-04 | Published |
2018-09-04 | Published for Opposition |
2019-02-26 | Location: PUBLICATION AND ISSUE SECTION |
2019-04-02 | Status: Live/Registered |
2019-04-02 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2019-04-02 | Trademark Registered |
2019-05-22 | Transaction Date |
2024-04-02 | Maintenance Early File Date |
2025-04-02 | Maintenance On Time Date |
2025-10-02 | Maintenance Late Fee Date |
Party: | Cycle Pharmaceuticals Ltd. |
Address | Bailey Grundy Barrett Building Little St Mary's Lane Cambridge UNITED KINGDOM CB21RR |
Legal Entity Type | Corporation |
Legal Entity State | UNITED KINGDOM |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | (Based on 44(e)) Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system, pharmaceutical agents for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system, pharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system, supplements for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system, biological preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system, chemical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of disorders of the metabolism and digestive system, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system, drugs for the treatment of rare diseases, in particular for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of disorders of the metabolism and digestive system, enzyme preparations for the treatment of tyrosinemia and hypertyrosinemia, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems, medical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches |
GS0051 | (Based on 44(e)) Pharmaceutical agents for the treatment of disorders of the metabolism and digestive system, pharmaceutical agents for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; parts and fittings for all of the aforementioned goods.; pharmaceutical preparations for the treatment of disorders of the metabolism and digestive system, pharmaceutical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of disorders of the metabolism and digestive system, pharmaceuticals for the treatment of tyrosinemia and hypertyrosinemia all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Veterinary preparations for treatment of intestinal bacteria; veterinary preparations, namely, antioxidants; veterinary preparations namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of disorders of the metabolism and digestive system, supplements for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; (Based on Use in Commerce) food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of disorders of the metabolism and digestive system, biological preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of disorders of the metabolism and digestive system, chemical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of disorders of the metabolism and digestive system, drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of disorders of the metabolism and digestive system, drugs for the treatment of rare diseases, in particular for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of disorders of the metabolism and digestive system, enzyme preparations for the treatment of tyrosinemia and hypertyrosinemia, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of disorders of the metabolism and digestive systems, medical preparations for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of disorders of the metabolism and digestive system, medicines for the treatment of tyrosinemia and hypertyrosinemia, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches |
Description | Date |
---|---|
Trademark Assignment 7075-0939 [6 Pages] | 2020-10-13 |
Description | Date | Proceeding Number |
---|---|---|
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-03-15 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-03-15 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-03-15 | |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-10-28 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-05-20 | |
REGISTERED-PRINCIPAL REGISTER | 2019-04-02 | |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2019-02-27 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-02-26 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-02-26 | |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2019-02-26 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-02-25 | |
SU - NON-FINAL ACTION - WRITTEN | 2019-02-15 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-02-15 | |
NON-FINAL ACTION E-MAILED | 2019-02-15 | |
STATEMENT OF USE PROCESSING COMPLETE | 2019-02-14 | |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-02-14 | |
USE AMENDMENT FILED | 2019-01-23 | |
TEAS STATEMENT OF USE RECEIVED | 2019-01-23 | |
CORRECTED NOA E-MAILED | 2019-01-17 | |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-10-30 | |
PUBLISHED FOR OPPOSITION | 2018-09-04 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-09-04 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-08-15 | |
ASSIGNED TO EXAMINER | 2018-08-10 | |
ELECTRONIC RECORD REVIEW COMPLETE | 2018-08-01 | |
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2018-07-27 | |
ELECTRONIC RECORD REVIEW COMPLETE | 2018-07-24 | |
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2018-07-13 | |
ELECTRONIC RECORD REVIEW COMPLETE | 2018-07-12 | |
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2018-06-29 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-06-27 | |
EXAMINERS AMENDMENT E-MAILED | 2018-06-27 | |
EXAMINERS AMENDMENT -WRITTEN | 2018-06-27 | |
EXAMINER'S AMENDMENT ENTERED | 2018-06-27 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-06-27 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-06-20 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-06-20 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-06-11 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-05-01 | |
NON-FINAL ACTION WRITTEN | 2018-05-01 | |
NON-FINAL ACTION E-MAILED | 2018-05-01 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-04-11 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-04-11 | |
ASSIGNED TO LIE | 2018-04-05 | |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-03-22 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2017-12-19 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-12-14 | |
NON-FINAL ACTION WRITTEN | 2017-12-14 | |
NON-FINAL ACTION E-MAILED | 2017-12-14 | |
ASSIGNED TO EXAMINER | 2017-12-14 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2017-09-15 | |
NEW APPLICATION ENTERED | 2017-09-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.